[ Pobierz całość w formacie PDF ]
306. Oyarzabal J, Pastor J. 2004. MARS approach for CNS activity of compound libraries using sub-
drug discovery: Aiding decision-making in in-silico structure analysis. J Chem Inf Comput Sci 43:
ADME EuroQSAR. 15th European Symposium on 155 160.
Structure-Activity Relationships (QSAR) and 314. Andres C, Hutter MC. 2006. CNS permeability of
Molecular Modelling, 219 220. drugs predicted by a decision tree. QSAR Comb Sci
307. Li WX, Li L, Eksterowicz J, Ling XB, Cardozo M. 25:305 309.
2007. Significance analysis and multiple pharma- 315. Hou T, Xu X. 2002. ADME evaluation in drug
cophore models for differentiating P-glycoprotein discovery. J Mol Model 8:337 349.
substrates. J Chem Inf Model 47:2429 2438. 316. Francis K, van Beek J, Canova C, Neal JW,
308. Pardridge WM. 2002. Drug and gene targeting to Gasque P. 2003. Innate immunity and brain
the brain with molecular Trojan horses. Nature inflammation: the key role of complement. Exp
Drug Discov Rev 1:131 139. Rev Mol Med 5:1 19.
309. Pardridge WM, Boado RJ. 2008. Agents capable of
crossing blood-brain barrier by receptor-mediated
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 12, DECEMBER 2009 DOI 10.1002/jps
[ Pobierz całość w formacie PDF ]
zanotowane.pldoc.pisz.plpdf.pisz.plcs-sysunia.htw.pl
|
